Correlation Between IShares Expanded and IShares Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Expanded and IShares Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Expanded and IShares Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Expanded Tech Software and iShares Pharmaceuticals ETF, you can compare the effects of market volatilities on IShares Expanded and IShares Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Expanded with a short position of IShares Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Expanded and IShares Pharmaceuticals.

Diversification Opportunities for IShares Expanded and IShares Pharmaceuticals

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between IShares and IShares is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding iShares Expanded Tech Software and iShares Pharmaceuticals ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Pharmaceuticals and IShares Expanded is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Expanded Tech Software are associated (or correlated) with IShares Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Pharmaceuticals has no effect on the direction of IShares Expanded i.e., IShares Expanded and IShares Pharmaceuticals go up and down completely randomly.

Pair Corralation between IShares Expanded and IShares Pharmaceuticals

Considering the 90-day investment horizon iShares Expanded Tech Software is expected to generate 1.74 times more return on investment than IShares Pharmaceuticals. However, IShares Expanded is 1.74 times more volatile than iShares Pharmaceuticals ETF. It trades about 0.08 of its potential returns per unit of risk. iShares Pharmaceuticals ETF is currently generating about 0.05 per unit of risk. If you would invest  8,533  in iShares Expanded Tech Software on September 1, 2024 and sell it today you would earn a total of  1,943  from holding iShares Expanded Tech Software or generate 22.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

iShares Expanded Tech Software  vs.  iShares Pharmaceuticals ETF

 Performance 
       Timeline  
iShares Expanded Tech 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Expanded Tech Software are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, IShares Expanded showed solid returns over the last few months and may actually be approaching a breakup point.
iShares Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Pharmaceuticals ETF has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, IShares Pharmaceuticals is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

IShares Expanded and IShares Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Expanded and IShares Pharmaceuticals

The main advantage of trading using opposite IShares Expanded and IShares Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Expanded position performs unexpectedly, IShares Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Pharmaceuticals will offset losses from the drop in IShares Pharmaceuticals' long position.
The idea behind iShares Expanded Tech Software and iShares Pharmaceuticals ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments